Back to today’s briefing

Story perspectives

FDA Warns on Weight-Loss Drugs; New Hope Emerges

3/13/2025

27 6

Summary

Story summary

The FDA has issued a warning about the dangers of off-brand weight-loss drugs like Ozempic and Wegovy, raising safety alarms. In a promising breakthrough, Stanford Medicine researchers have identified a peptide, BRINP2-related peptide (BRP), that may curb appetite and aid weight loss without harsh side effects, offering hope to over 100 million obese adults in the U.S.

1 of 1

Story summary

The FDA has issued a warning about the dangers of off-brand weight-loss drugs like Ozempic and Wegovy, raising safety alarms. In a promising breakthrough, Stanford Medicine researchers have identified a peptide, BRINP2-related peptide (BRP), that may curb appetite and aid weight loss without harsh side effects, offering hope to over 100 million obese adults in the U.S.